BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 20526224)

  • 1. Comparison of scoring approaches for the NEI VFQ-25 in low vision.
    Dougherty BE; Bullimore MA
    Optom Vis Sci; 2010 Aug; 87(8):543-8. PubMed ID: 20526224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a new Rasch-based scoring algorithm for the National Eye Institute Visual Functioning Questionnaire to improve its interpretability.
    Petrillo J; Bressler NM; Lamoureux E; Ferreira A; Cano S
    Health Qual Life Outcomes; 2017 Aug; 15(1):157. PubMed ID: 28807029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remediating serious flaws in the National Eye Institute Visual Function Questionnaire.
    Pesudovs K; Gothwal VK; Wright T; Lamoureux EL
    J Cataract Refract Surg; 2010 May; 36(5):718-32. PubMed ID: 20457362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cross-cultural validation of the National Eye Institute Visual Function Questionnaire.
    Mollazadegan K; Huang J; Khadka J; Wang Q; Yang F; Gao R; Pesudovs K
    J Cataract Refract Surg; 2014 May; 40(5):774-84. PubMed ID: 24767911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation and comparison of the National Eye Institute Visual Functioning Questionnaire-25 (NEI VFQ-25) and the Visual Function Index-14 (VF-14) in patients with cataracts: a multicentre study.
    Wan Y; Zhao L; Huang C; Xu Y; Sun M; Yang Y; An L; Lv S; Yu Y; Chen D; Zhou P; Wang Y; Zhang M; Jiang A; Chen Z; Li X
    Acta Ophthalmol; 2021 Jun; 99(4):e480-e488. PubMed ID: 32940410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychometric properties of the Greek version of the NEI-VFQ 25.
    Labiris G; Katsanos A; Fanariotis M; Tsirouki T; Pefkianaki M; Chatzoulis D; Tsironi E
    BMC Ophthalmol; 2008 Mar; 8():4. PubMed ID: 18325083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using the VA LV VFQ-48 and LV VFQ-20 in low vision rehabilitation.
    Stelmack JA; Massof RW
    Optom Vis Sci; 2007 Aug; 84(8):705-9. PubMed ID: 17700334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the NEI visual functioning questionnaire as an interval measure of visual ability in low vision.
    Massof RW; Fletcher DC
    Vision Res; 2001 Feb; 41(3):397-413. PubMed ID: 11164454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An interval-scaled scoring algorithm for visual function questionnaires.
    Massof RW
    Optom Vis Sci; 2007 Aug; 84(8):E690-705. PubMed ID: 17700325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychometric performance of the National Eye Institute visual function questionnaire in Latinos and non-Latinos.
    Baker RS; Bazargan M; Calderón JL; Hays RD
    Ophthalmology; 2006 Aug; 113(8):1363-71. PubMed ID: 16877075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The psychometric validity of the NEI VFQ-25 for use in a low-vision population.
    Marella M; Pesudovs K; Keeffe JE; O'Connor PM; Rees G; Lamoureux EL
    Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):2878-84. PubMed ID: 20089878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of the 25-item National Eye Institute Visual Function Questionnaire.
    Mangione CM; Lee PP; Gutierrez PR; Spritzer K; Berry S; Hays RD;
    Arch Ophthalmol; 2001 Jul; 119(7):1050-8. PubMed ID: 11448327
    [TBL] [Abstract][Full Text] [Related]  

  • 13. National Eye Institute Visual Function Questionnaire or Indian Vision Function Questionnaire for visually impaired: a conundrum.
    Gothwal VK; Reddy SP; Sumalini R; Bharani S; Bagga DK
    Invest Ophthalmol Vis Sci; 2012 Jul; 53(8):4730-8. PubMed ID: 22700705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of a vision-related activity scale for patients with retinitis pigmentosa.
    Costela FM; Pesudovs K; Sandberg MA; Weigel-DiFranco C; Woods RL
    Health Qual Life Outcomes; 2020 Jun; 18(1):196. PubMed ID: 32571342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Piloting Rasch model scoring of the National Eye Institute Visual Function Questionnaire in uveitis.
    Gittel L; Li JQ; Dell J; Wintergerst MWM; Heinz C; Finger RP; Terheyden JH
    J Ophthalmic Inflamm Infect; 2024 Apr; 14(1):16. PubMed ID: 38625428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validation and cross-cultural adaptation of the National Eye Institute Visual Function Questionnaire (NEI VFQ-25) in Serbian patients.
    Kovac B; Vukosavljevic M; Djokic Kovac J; Resan M; Trajkovic G; Jankovic J; Smiljanic M; Grgurevic A
    Health Qual Life Outcomes; 2015 Sep; 13():142. PubMed ID: 26370558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliability and validity of the National Eye Institute Visual Function Questionnaire-25 in patients with age-related macular degeneration.
    Revicki DA; Rentz AM; Harnam N; Thomas VS; Lanzetta P
    Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):712-7. PubMed ID: 19797233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reliability and validity of abbreviated surveys derived from the National Eye Institute Visual Function Questionnaire: the study of osteoporotic fractures.
    Kodjebacheva G; Coleman AL; Ensrud KE; Cauley JA; Yu F; Stone KL; Pedula KL; Hochberg MC; Mangione CM
    Am J Ophthalmol; 2010 Feb; 149(2):330-40. PubMed ID: 20103058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes After Comprehensive Vision Rehabilitation Using Vision-related Quality of Life Questionnaires: Impact of Vision Impairment and National Eye Institute Visual Functioning Questionnaire.
    Selivanova A; Fenwick E; Man R; Seiple W; Jackson ML
    Optom Vis Sci; 2019 Feb; 96(2):87-94. PubMed ID: 30589760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the National Eye Institute visual function questionnaire in Graves' ophthalmopathy.
    Bradley EA; Sloan JA; Novotny PJ; Garrity JA; Woog JJ; West SK
    Ophthalmology; 2006 Aug; 113(8):1450-4. PubMed ID: 16769116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.